MARIE-CLAUDE GINGRAS to Cell Line, Tumor
This is a "connection" page, showing publications MARIE-CLAUDE GINGRAS has written about Cell Line, Tumor.
Connection Strength
0.219
-
Development and extensive sequencing of a broadly-consented Genome in a Bottle matched tumor-normal pair. Sci Data. 2025 Jul 16; 12(1):1195.
Score: 0.034
-
?-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus. World J Gastroenterol. 2023 Jul 28; 29(28):4416-4432.
Score: 0.030
-
NF-?B and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells. Life Sci. 2020 Dec 01; 262:118548.
Score: 0.025
-
Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016 Mar 03; 531(7592):47-52.
Score: 0.018
-
Functional annotation of rare gene aberration drivers of pancreatic cancer. Nat Commun. 2016 Jan 25; 7:10500.
Score: 0.018
-
Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth. Mol Cell. 2015 Oct 15; 60(2):195-207.
Score: 0.017
-
PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform. PLoS One. 2012; 7(8):e40452.
Score: 0.014
-
Genomic sequencing of key genes in mouse pancreatic cancer cells. Curr Mol Med. 2012 Mar; 12(3):331-41.
Score: 0.014
-
SSTR5 P335L monoclonal antibody differentiates pancreatic neuroendocrine neuroplasms with different SSTR5 genotypes. Surgery. 2011 Dec; 150(6):1136-42.
Score: 0.013
-
The hypofunctional effect of P335L single nucleotide polymorphism on SSTR5 function. World J Surg. 2011 Aug; 35(8):1715-24.
Score: 0.013
-
PDX-1: demonstration of oncogenic properties in pancreatic cancer. Cancer. 2011 Feb 15; 117(4):723-33.
Score: 0.012
-
PDX-1 acts as a potential molecular target for treatment of human pancreatic cancer. Pancreas. 2008 Aug; 37(2):210-20.
Score: 0.011